Physician profile
Keri L Lowe
NPI 1609476456
$7,877.45
in general payments reported to CMS, 2019-2025
41 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what 96% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,704 · 2022: $2,164 · 2023: $1,609 · 2024: $1,136 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,945 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,944.54 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,957.96 | 2021-2025 | |
| Novo Nordisk INC | $1,337.35 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $677.04 | 2021-2025 | Mounjaro, Emgality, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $630.27 | 2021-2025 | Airsupra, Farxiga |
| Amgen INC. | $468.04 | 2021-2025 | Repatha, Otezla, Repatha |
| E.R. Squibb & Sons, L.L.C. | $274.18 | 2021-2025 | Eliquis |
| Pfizer INC. | $251.94 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $222.07 | 2022-2024 | |
| Amarin Pharma, INC. | $193.07 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $174.93 | 2023-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.61 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $165.49 | 2021-2024 | |
| Glaxosmithkline, LLC. | $163.39 | 2022-2025 | Trelegy Ellipta |
| Astellas Pharma US INC | $117.45 | 2021-2024 | Veozah |
| Janssen Pharmaceuticals, INC | $109.73 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keri Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.